| | | |

Celiac Disease May Be a Little-Known Complication of Mesothelioma Immunotherapy

mesothelioma immunotherapyA new French case report shines a spotlight on a little-known potential complication of mesothelioma immunotherapy: celiac disease. 

Celiac disease is a chronic digestive and immune disorder brought on by sensitivity to gluten. Over time, celiac disease damages the small intestine causing long-lasting digestive problems. It can prevent patients from getting the nutrients they need to stay healthy. 

The new case report appears in Frontiers in Immunology. It details the case of a 70-year-old man who developed celiac disease after treatment with nivolumab. The case suggests that celiac disease may be an underrecognized side effect of mesothelioma immunotherapy.

It is a reminder for mesothelioma patients and doctors to pay close attention to digestive problems after treatment. 

Stimulating the Immune System to Fight Cancer

Standard cancer treatments rarely extend mesothelioma survival by more than a few months. This has forced mesothelioma researchers to look elsewhere for answers. Mesothelioma immunotherapy is considered one of the most promising new approaches to this intractable malignancy. 

Immunotherapy uses the power of patients’ own immune systems to fight their cancer. 

In 2020, the FDA approved two immune checkpoint inhibitors (ICIs) for pleural mesothelioma. The drugs are nivolumab (Opdivo) and ipilimumab (Yervoy). One of these drugs  increases the number of cancer-killing immune cells in a mesothelioma tumor. The other drug alters mesothelioma cells to make them more susceptible to attack. 

Three years after the last mesothelioma patients enrolled in the mesothelioma immunotherapy trial of these two drugs, nearly a quarter were still alive. Most mesothelioma patients do not live more than a year after diagnosis. 

Mesothelioma Immunotherapy Can Cause Side Effects

Manipulating the immune system is not without risk. The American Society for Clinical Oncology says the side effects of mesothelioma immunotherapy can range from mild to life-threatening. 

Common side effects of immune checkpoint inhibitors like Yervoy and Opdivo include:

  • Rashes & itching
  • Diarrhea
  • Joint pain and/or swelling
  • Nervous system problems
  • Lung inflammation
  • Thyroid disorders

But there may be another one to add to the list. The patient in the French case study was on nivolumab when he developed diarrhea. Further testing showed he had celiac disease. Doctors gave him steroids to calm his immune system and put him on a gluten free diet. Unfortunately, this patient’s case may not be unique. 

“Increasing reports suggest that celiac disease might represent an underestimated ICI toxicity,” writes first author Julie Leblanc, a medical oncologist at Aix-Marseille University.

The team cautions cancer doctors to monitor unusual gastrointestinal symptoms in patients on mesothelioma immunotherapy. 

“This case highlights the necessity of complementary investigation (including tTG-IgA and endoscopic biopsies) in patients with atypical digestive symptoms during immunotherapy,” writes Leblanc. 

Source: 

Leblanc, J, et al, “Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report”, December 17, 2021, Frontiers in Immunology, https://www.frontiersin.org/articles/10.3389/fimmu.2021.799666/full

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…